Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (4208)

Showing 12 of 4208 View All
Showing 96 of 351 pages

Mozambique had no data about snakebites. Our new study filled the gap – and the results are scary

Even by conservative estimates, Mozambique’s snakebite figures are far higher than previously thought.

Tracking routine immunisation in rural Zimbabwe

A tool designed to drive engagement between health workers and community members is working wonders in rural Zimbabwe.

Emergency health camps offer a lifeline to flood-affected families in Pakistan

To stem the potential health risks from the flooding, the government is establishing emergency health camps.

Five things you need to know about COVID-19 vaccines and your period

Data shows that getting vaccinated can temporarily affect your period, but that the change is temporary.

5 things to know about COVAX in September 2022

September saw good progress in history’s largest vaccine rollout, with COVID-19 vaccine coverage continuing to increase in lower-income countries and civil society finding its voice. Managing Director of the COVAX Facility, Dr Derrick Sim, gives…

Millions to benefit from Indian-made cervical cancer vaccine

A new human papillomavirus (HPV) vaccine has been launched by the Serum Institute of India, offering a low-cost alternative to vaccines on the market.

Five takeaways from WHO’s immunisation advisory committee

Last week WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization met to discuss COVID-19 boosters, monkeypox, Ebola, polio and measles, among other concerns. Here’s what they decided.

Five charts on 15 years of the HPV vaccine

More than 15 years have passed since the first HPV vaccine introduction, and real-world evidence for its effectiveness is now well established. However the global burden of HPV-related cervical cancer has shifted to lower-income countries, where…

How story-telling is helping girls access the HPV vaccine in Ethiopia and Tanzania

Girls and women hold the key to improving access to healthcare for families across Ethiopia and Tanzania, starting with the HPV vaccine.

“A pivotal moment”: Sierra Leone makes HPV vaccine available to girls across country

More than 150,000 girls across Sierra Leone will have access to the HPV vaccine after the government introduced it into the routine immunisation programme.

Rift Valley fever: What’s next for the climate-driven disease with epidemic potential?

CEPI Vaccine R&D Project Leader, Mike Whelan, discusses the characteristics of the disease and CEPI's new call with the European Union to advance Rift Valley fever vaccines.

My third COVID-19 infection: Why reinfection can be anything but mild

Vaccination and natural immunity have dramatically reduced the death toll from COVID-19, but catching COVID-19 for a third time is still no walk in the park, as Linda Geddes discovered last week.

Subscribe to our newsletter